Merus Labs International Inc (USA) news

   Watch this stock
Showing stories 1 - 10 of about 23   

Articles published

MSLI 1.28 +0.02 (1.59%)
price chart
How Many Merus Labs International Inc (USA) (NASDAQ:MSLI)'s Analysts Are Bullish?
Out of 3 analysts covering Merus Labs International (NASDAQ:MSLI), 3 rate it a “Buy”, 0 “Sell”, while 0 “Hold”.
Merus Labs International Incorporated (NASDAQ:MSLI) Shorted Shares Increased ...
The stock of Merus Labs International Incorporated (NASDAQ:MSLI) registered an increase of 26.03% in short interest. MSLI's total short interest was 1.84 million shares in July as published by FINRA.
Slow Growth Ahead; Updates on Merus Labs International, Enghouse Systems ...
Background: Merus Labs is a specialty pharmaceutical company focused on acquiring established products. The company leverages its expertise in European and North American markets to optimize the value of underdeveloped pharmaceutical assets.
Merus Labs International: A Pharma Stock With Growth Potential
It's Merus Labs International Inc. (TSX: MSL) (NASDAQ:MSLI), a specialty pharmaceutical company focused on acquiring established products.
Merus Labs acquires Emselex rights from Novartis for Canada and Europe
Specialty pharmaceutical company Merus Labs International (TSE:MSL) said Wednesday it acquired from Novartis Pharma the Canadian and European rights to Emselex, a treatment for overactive bladder.
Plus the latest data from on 21 home markets across the US
Diversity of Lilly's Alzheimer's Disease Pipeline Showcased at the Alzheimer's Association International Conference� 2016 (AAIC� 2016) ... Merus Labs Appoints Two New Senior Executives .... Copyright � 2016 MarketWatch, Inc. All rights reserved. By ...
Cornerstone Diversifies Hospital Portfolio, Buys EKR for $125M
In reviewing the company's first-quarter performance, Collard said Cornerstone eliminated its primary care product line with the March sale of Factive to Merus Labs International Inc., of Toronto, and Spectracef (cefditoren pivoxil) to Vansen Pharma Inc.
In-house training solutions from PTI: save time and cost in upskilling staff
Pharmaceutical Training International (PTI), the leading supplier of online and public event-based training courses for the pharma, biotech and medical device sectors, is delivering high quality in-house tailored training solutions to all organisations ...
Court Report
India Pvt. Ltd.; Aurobindo Pharma Ltd.; Aurobindo Pharma USA Inc.; Dr. Reddy's Laboratories, Ltd.; Dr. Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Ltd.; ...
Related articles »  
Biopharmaceutical Contract Manufacturing Market to 2025 - Market To Grow At An ...
The Biopharmaceutical Contract Manufacturing Market, 2015 - 2025' report provides an extensive study of the contract manufacturing market for biopharmaceuticals.